ALSO NOTED: Barrier Therapeutics plans $25M IPO; Innogenetics awarded $7M in Abbott dispute; and much more...

> Cytyc says its $374 million bid for Australia's Vision Systems offers investors more money and a quicker deal than Ventana Medical Systems' competing bid. Report

> Barrier Therapeutics plans to raise $25 million in a public offering. Report

> Belgium's Innogenetics announced that a jury had awarded it $7 million in a patent dispute with Abbott Laboratories. Report

> Chutes & Ladders: Omega Pharma has promoted Jan Cassiman to CEO, replacing Marc Coucke. Report

> Chutes & Ladders: BioBalance CEO Dennis O'Donnell has resigned. Release

And Finally... After virtually disappearing, whooping cough is back and physicians are mounting a new campaign calling for a fresh round of vaccinations. Article